The first reported case of neonatal alloimmune thrombocytopenia due to low-frequency human platelet antigen-6b antibodies in the United Kingdom.
hematology
immune thrombocytopenia
platelet transfusion
platelets
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
17
05
2021
received:
01
03
2021
accepted:
02
06
2021
pubmed:
23
6
2021
medline:
9
11
2021
entrez:
22
6
2021
Statut:
ppublish
Résumé
Neonatal alloimmune thrombocytopenia (NAIT) is a potentially serious clinical condition caused by maternal alloantibodies directed to human platelet antigens (HPA), inherited from the father and expressed on fetal/neonatal platelets. We report a case of an otherwise well, full term child, with a profound thrombocytopenia (33 x 109/L). There was no bleeding or obvious explanation for the low platelet count. Samples were sent for the investigation of NAIT. Serological investigations were performed on maternal serum taken at day (D)+4 and D+78. The platelet immunofluorescence test (PIFT) and monoclonal antibody immobilization of platelet antigens (MAIPA) assays were performed with a panel of HPA typed donor platelets and against paternal platelets in a crossmatch. HPA 1-6, -9 and -15 and HLA genotyping was performed by in-house PCR-sequence based typing (SBT) and next generation sequencing (NGS). HPA antibody screening of D+4 maternal serum indicated that platelet-specific antibodies were absent. HPA genotyping of the father and child revealed the presence of the low frequency HPA antigen (LFHPA), HPA-6b, which was absent in the mother. Maternal samples were crossmatched against paternal platelets and were positive by PIFT and glycoprotein (GP) IIb/IIIa and HLA class I in the MAIPA assay. The infant required no platelet transfusion support as the thrombocytopenia resolved spontaneously. We conclude that the positive crossmatch reaction was due to anti-HPA-6b alloantibodies. This case further emphasizes the importance of platelet crossmatching and HPA genotyping of LFHPA in cases where there is a high clinical suspicion of NAIT but initial screening is negative.
Sections du résumé
BACKGROUND
Neonatal alloimmune thrombocytopenia (NAIT) is a potentially serious clinical condition caused by maternal alloantibodies directed to human platelet antigens (HPA), inherited from the father and expressed on fetal/neonatal platelets. We report a case of an otherwise well, full term child, with a profound thrombocytopenia (33 x 109/L). There was no bleeding or obvious explanation for the low platelet count. Samples were sent for the investigation of NAIT.
METHOD
Serological investigations were performed on maternal serum taken at day (D)+4 and D+78. The platelet immunofluorescence test (PIFT) and monoclonal antibody immobilization of platelet antigens (MAIPA) assays were performed with a panel of HPA typed donor platelets and against paternal platelets in a crossmatch. HPA 1-6, -9 and -15 and HLA genotyping was performed by in-house PCR-sequence based typing (SBT) and next generation sequencing (NGS).
RESULTS
HPA antibody screening of D+4 maternal serum indicated that platelet-specific antibodies were absent. HPA genotyping of the father and child revealed the presence of the low frequency HPA antigen (LFHPA), HPA-6b, which was absent in the mother. Maternal samples were crossmatched against paternal platelets and were positive by PIFT and glycoprotein (GP) IIb/IIIa and HLA class I in the MAIPA assay. The infant required no platelet transfusion support as the thrombocytopenia resolved spontaneously.
DISCUSSION
We conclude that the positive crossmatch reaction was due to anti-HPA-6b alloantibodies. This case further emphasizes the importance of platelet crossmatching and HPA genotyping of LFHPA in cases where there is a high clinical suspicion of NAIT but initial screening is negative.
Substances chimiques
6b alloantigen, human
0
Antigens, Human Platelet
0
Isoantibodies
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
2788-2794Informations de copyright
© 2021 AABB.
Références
Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329:1463-6.
Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161:3-14.
Brojer E, Husebekk A, Debska M, Uhrynowka M, Guz K, Orzinaska A, et al. Fetal/neonatal alloimmune thrombocytopenia: pathogenesis diagnostics and prevention. Arch Immunol Ther Exp (Warsz). 2016;64:279-90.
Ghevart C, Rankin A, Huiskes E, Porcelijn L, Javela K, Kekomaki R, et al. Alloantibodies against low-frequency human platelet antigens do not account for a significant proportion of cases of fetomaternal alloimmune thrombocytopenia: evidence from 1054 cases. Transfusion. 2009;49:2084-9.
Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune neonatal thrombocytopenia. Lancet. 1989;1:363-6.
Peterson JA, Gitter M, Bougie DW, Pechauer S, Hopp KA, Pietz B, et al. Low frequency human platelet antigens (HPA) as triggers for neonatal alloimmune thrombocytopenia. Transfusion. 2014;54:1286-93.
Poles A, Wozniak MJ, Walser P, Ridgwell K, Fitzgerald J, Green A, et al. A V740L mutation in glycoprotein IIb defines a novel epitope (war) associated with fetomaternal alloimmune thrombocytopenia. Transfusion. 2013;53:1965-73.
Versiti. HPA database. 2020. https://www.versiti.org/medical-professionals/precision-medicine-expertise/platelet-antigen-database#hpa-database. Accessed 25 Sept 2020.
Peterson JA, Balthazor SM, Curtis BR, McFarland JG, Aster H. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Maxa) is an important cause of neonatal alloimmune thrombocytopenia. Transfusion. 2005;45:1487-95.
Wang R, McFarland JG, Kekomaki R, Newman PJ. Amino acid 489 is encoded by a mutational “hot spot” on the beta 3 integrin chain: the CA/TU human platelet alloantigen system. Blood. 1993;82:3386-91.
Westman P. Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmuization against human platelet alloantigen HPA-6b (GPIIIa-Gln489). Tissue Antigens. 1997;50:113-8.
European Bioinformatics Institute. HPA allele frequencies. 2020. https://www.ebi.ac.uk/ipd/hpa/freqs_1.html. Accessed 21 Sept 2020.
McFarland JG, Blanchette V, Collins J, Newman PJ, Wang R, Aster RH. Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody. Blood. 1993;81:3318-23.
Sainio S, Teramo K, Kekomaki R. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia. Transfus Med. 1999;9:321-30.
Kekomaki R, Jouhikainen T, Ollikainen J, Westman P, Laes M. A new platelet alloantigen, Tua on glycoprotein IIIa associated with neonatal alloimmune thrombocytopenia in two families. Br J Haematol. 1993;83:1365-2141.
von dem Borne AE, Verheugt FW, Oosterhof F, von Riesz E, de la Rivière AB, Engelfriet CP. PIFT a simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol. 1978;39:195-207.
Campbell K, Rishi K, Howkins G, Gilby D, Mushens R, Ghevaert C, et al. A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation. Vox Sang. 2007;93:289-97.
Dahl J, Refsum E, Ahlen MT, Egeland T, Jensen T, Viken MK, et al. Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-antibody specificity analysis using epitope data. J Reprod Immunol. 2017;122:1-9.
Sachs UJ, Wienzek-Lischka S, Duong Y, Qiu D, Hinrichs W, Cooper N, et al. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia. Br J Haematol. 2020;189:751-9.
Meler E, Porta R, Canels C, Serra B, Lozano M. Fatal alloimmune thrombocytopenia due to anti-HLA alloimmunization in a twin pregnancy: a very infrequent complication of assisted reproduction. Transfus Apher Sci. 2017;56:165-7.
Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, et al.; International Collaboration for Transfusion Medicine Guidelines (ICTMG)Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach. Br J Haematol. 2019;185:549-62.
Davey S, Navarrete C, Brown C. Simultaneous human platelet antigen genotyping and detection of novel single nucleotide polymorphisms by targeted next-generation sequencing. Immunohaematology. 2017;57:1497-504.